Personal information

No personal information available

Activities

Employment (3)

Mass General Brigham: Boston, MASSACHUSETTS, US

2023-07-01 to present | Resident (Pathology)
Employment
Source: Self-asserted source
Maria Cristina Riascos

Weill Cornell Medicine: New York, NY, US

2022-03-01 to 2023-06-30 | Research Fellow (Radiology)
Employment
Source: Self-asserted source
Maria Cristina Riascos

Weill Cornell Medicine: New York, NY, US

2021-07-01 to 2023-06-30 | Research Fellow (Surgery)
Employment
Source: Self-asserted source
Maria Cristina Riascos

Education and qualifications (1)

Universidad Central de Venezuela Facultad de Medicina: Caracas, Distrito Capital, VE

2012-07-01 to 2018-12-11 | MD (Escuela de Medicina Jose Maria Vargas)
Education
Source: Self-asserted source
Maria Cristina Riascos

Works (13)

Expanding Our Knowledge of DICER1 Gene Alterations and Their Role in Thyroid Diseases

Cancers
2024-01-13 | Journal article
Contributors: Maria Cristina Riascos; Anh Huynh; William C. Faquin; Vania Nosé
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma

Molecular Cancer Research
2023-05-01 | Journal article
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Data from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-05-01 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Data from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-05-01 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Supplementary Figures 1-7 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-05-01 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Supplementary Figures 1-7 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-05-01 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Supplementary Tables 1-5 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-05-01 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Supplementary Tables 1-5 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-05-01 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Data from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-04-03 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Supplementary Figures 1-7 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-04-03 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Supplementary Figures 1-7 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-04-03 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Supplementary Tables 1-5 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-04-03 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref

Supplementary Tables 1-5 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid Carcinoma

2023-04-03 | Preprint
Contributors: Jessica Limberg; Caitlin E. Egan; Katherine D. Gray; Mandeep Singh; Zachary Loewenstein; Yanping Yang; Maria Cristina Riascos; Hala Al Asadi; Parima Safe; Steve El Eshaky et al.
Source: check_circle
Crossref